TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effectsBRITISH JOURNAL OF PHARMACOLOGYIF7.72020-09-2110OAAI
Development of the First Two-Pore Domain Potassium Channel TWIK-Related K+ Channel 1-Selective Agonist Possessing in Vivo Antinociceptive ActivityJOURNAL OF MEDICINAL CHEMISTRYIF6.82017-01-2052PREAI
Role of the TREK2 potassium channel in cold and warm thermosensation and in pain perceptionPAINIF5.52014-12-01113PREAI
Activation of TREK-1 by morphine results in analgesia without adverse side effectsNATURE COMMUNICATIONSIF15.72013-12-1771OA